RRC ID 81312
Author Nakayama K, Onishi H, Fujimura A, Imaizumi A, Kawamoto M, Oyama Y, Ichimiya S, Koga S, Fujimoto Y, Nakashima K, Nakamura M.
Title NFκB and TGFβ contribute to the expression of PTPN3 in activated human lymphocytes.
Journal Cell Immunol
Abstract We previously reported that protein tyrosine phosphatase non-receptor type 3 (PTPN3), which is upregulated in activated lymphocytes, acts as an immune checkpoint. However, the mechanism by which PTPN3 expression is enhanced in activated lymphocytes is unknown. In this study, we analyzed the mechanism of PTPN3 expression in activated lymphocytes with a view for developing a novel immune checkpoint inhibitor that suppresses PTPN3. Through the activation process, lymphocytes showed enhanced NFκB activation as well as increased PTPN3 expression. NFκB enhanced proliferation, migration, and cytotoxicity of lymphocytes. Furthermore, NFκB enhanced PTPN3 expression and tyrosine kinase activation. TGFβ reduced PTPN3 expression and NFκB activation in the cancer microenvironment, and suppressed the biological activity of lymphocytes. The results of this study are expected to provide significant implications for improving existing immunotherapy and developing novel immunotherapy.
Volume 358
Pages 104237
Published 2020-12-1
DOI 10.1016/j.cellimm.2020.104237
PII S0008-8749(20)30397-X
PMID 33137650
MeSH Cell Line, Tumor Cell Proliferation / physiology Humans Lymphocyte Activation / immunology Lymphocytes / metabolism NF-kappa B / metabolism* NF-kappa B / physiology Phosphorylation / immunology Protein Tyrosine Phosphatase, Non-Receptor Type 3 / genetics Protein Tyrosine Phosphatase, Non-Receptor Type 3 / metabolism* Signal Transduction / immunology Transforming Growth Factor beta / metabolism* Transforming Growth Factor beta / physiology
IF 4.078
Resource
DNA material pCAG-HIVgp (RDB04394) pCMV-VSV-G-RSV-Rev (RDB04393)